Presented at ESCMID Global 2025
The Healix Research Team was honored to showcase our latest collaborative study with our esteemed physician partners and Melinta Therapeutics at ESCMIDGlobal, the prestigious Congress of the European Society of Clinical Microbiology and Infectious Diseases, which will be held April 11-15 in Vienna, Austria.
P2942: Real-World Experience with Rezafungin: A Novel Long-Acting Echinocandin
Authors:
Lucinda J. Van Anglen, BS, PharmD
Kimberly A. Couch, PharmD, MA, FIDSA, FASHP
Richard L. Hengel, MD
Brian S. Metzger, MD, MPH
Erika M. Young, DO
Stacey E. Baker, MD
Joseph F. John, Jr., MD, FACP, FIDSA